Diagnostics company LumiraDx announced it signed an agreement to sell its point-of-care technology to pharma giant Roche for $295 million, with an additional payment of $55 million to fund the platform until the acquisition closes.
LumiraDx developed a diagnostic testing system that uses a small, portable instrument and microfluidic test strips to perform multiple lab-quality tests via a single...
Brain-computer interface company Synchron announced its receipt of an oversubscribed $75 million Series C funding round, bringing its total raise to $145 million.
ARCH Venture Partners led the round with additional investment from Bezos Expeditions, Greenoaks, Alumni Ventures, Moore Strategic Ventures, Gates Frontier, Project X and Reliance Digital Health Limited.
The company's board of directors...
UK high street pharmacy, Boots is launching a new in-store COVID-19 nasal swab testing service to people who are not showing symptoms.
The technology has been developed by LumiraDx, who is also providing supplies to the NHS in Scotland.
The Lumira private COVID-19 test will cost £120 and will be available in 10 stores from this week, before rolling out to 50 Boots stores throughout November.
WHY...
